Building Global Consensus for Liquid Biopsies to Drive Universal Clinical Integration of Liquid Biopsy

• Building alignment across stakeholders on assay performance and interpretation, including diagnostic vendors, biopharma, consortia and others
• Reducing variability through shared standards and best practices, including standardizing parameters
• Enabling broader clinical integration through harmonized approaches

Speakers:

Lauren Leiman

Executive Director

BLOODPAC